 SOUTH SAN FRANCISCO, Calif., June 02, 2022 GLOBE NEWSWIRE -- NGM Biopharmaceuticals, Inc. NGM Bio Nasdaq: NGM, a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announced that David J. Woodhouse, Ph.D., Chief Executive Officer, will present an overview of the company and provide a business update at the following upcoming investor conferences. 